These findings reveal that lung disease progression in early CF, in addition to being correlated with demographic and clinical characteristics such as age, gender, severity of CFTR mutation and culture status, is also strongly associated with an increase in specific AA derivatives in the airways. This evidence concerns the gene CFTR and lung disorder.